No influence of the polymorphisms <it>CYP2C19 </it>and <it>CYP2D6 </it>on the efficacy of cyclophosphamide, thalidomide, and bortezomib in patients with Multiple Myeloma

by Vogel Ulla, Gregersen Henrik, Gimsing Peter, Abildgaard Niels, Andersen Niels F, Klausen Tobias W, Søeby Karen, Vangsted Annette J, Werge Thomas, Rasmussen Henrik B
Published 2010-08-01